Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Bath & Body Works (BBWI): +22% Upside to the $23 Analyst Target

Bath & Body Works (BBWI): +22% Upside to the $23 Analyst Target

Key Takeaways

  • The central target of $23 reflects the arithmetic mean of six recent, attributable analyst price targets, rounded from a calculated average of roughly $22.50.
  • With the stock near $18.91, reaching $23 implies an upside of about 22%, a substantial but not extreme move.
  • Verified individual targets cluster tightly between $20 and $25, although broader surveys report a much wider range—roughly $19 to $54—reflecting a few far more bullish forecasts.
  • The strongest supporting factors are a low valuation, a high dividend yield, and a recent earnings beat.
  • The biggest risks are persistent revenue declines, cautious "Hold" ratings, and heavy reliance on store traffic for the holiday quarter.
  • For additional detail on this name, explore the ticker's Major News, Today's Price Move, Forecast, and Earnings pages.
  • Readers looking for broader market ideas can also explore Trending AI Robots.

What Analysts Are Saying About BBWI

Bath & Body Works, Inc. (BBWI) is a specialty retailer focused on personal care and home fragrance products. I reviewed six recent, individually attributable price targets: $20 from Piper Sandler, $22 from Morgan Stanley, UBS, and Telsey Advisory, $24 from TD Cowen, and $25 from Wells Fargo. Their average comes to roughly $22.50, which rounds to the $23 central target used here.

The tight $20-to-$25 cluster among these firms points to a generally cautious stance, with most ratings at "Hold" or "Equal Weight." Only TD Cowen and Wells Fargo carry "Buy" ratings, leading to an overall consensus of "Hold." Broader aggregator surveys show a much wider span from about $19 to $54 because a handful of more optimistic estimates are still in circulation. That spread reminds us the average is simply a midpoint amid differing opinions rather than a firm prediction.

Recent moves have been modest. Morgan Stanley lifted its target to $22 from $20, and UBS raised its to $22 from $19 in mid-November, while TD Cowen trimmed its to $24 from $25. These incremental shifts, not sweeping changes, define the current analyst picture. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Price Level and the Road to $23

The shares last closed near $18.91, with intraday levels around $19.17. Hitting the $23 target would mean roughly a 22% advance. Market capitalization stands at about $3.8 billion, and the trailing P/E ratio sits under 5, underscoring investor caution about growth prospects rather than any sign of distress.

Reaching the target would likely need signs that revenue can stabilize or return to growth. Quarterly revenue has been running in the $1.5 billion to $1.6 billion range, and the most recent quarter (reported November 19, 2026) delivered EPS of $0.26 and revenue of $1.58 billion, both above expectations. Continued beats like this, paired with solid holiday results, would offer the clearest path to higher analyst estimates.

Elements That Could Support a Higher Price

A few factors stand out as potential supports. The valuation looks inexpensive with that low P/E and a dividend yield near 4.2%, which may draw income-focused investors during a turnaround period. The latest quarter beat expectations, which could encourage analysts to nudge targets upward over time. The company also holds a solid position in home fragrance and personal care, generating steady cash flow from its high-margin lineup.

If discretionary spending remains steady through the holidays and margins hold, the combination of attractive valuation and modest estimate revisions could allow for gradual multiple expansion toward the $20-to-$25 zone most analysts already reference.

Obstacles That Could Limit Upside

The main challenge remains the revenue trajectory. Projections in recent years have pointed to flat or modestly declining sales, and Bath & Body Works depends heavily on physical store traffic. A softer holiday period, softer consumer spending, or heavier promotions could weigh on both top-line results and margins.

The prevalence of "Hold" ratings also reflects limited conviction on Wall Street. Multiples may stay compressed without a clear growth catalyst, and the broad analyst range—with some targets at or below the current price—shows that any re-rating is far from assured. A guidance cut or margin shortfall could quickly stall the modest momentum seen so far.

Technical Levels Worth Watching

The stock has traded in a 52-week range of roughly $13.86 to $24.94. The $24-to-$25 zone marks notable resistance, aligning with both the 52-week high and several analyst targets. Support has appeared in the $17-to-$18 area recently, while the $20 level serves as a psychological hurdle the shares would need to clear and hold before a sustained push toward $23 looks realistic.

Time Horizon and Items to Monitor

Analyst targets generally reflect a 12-month horizon, though exact periods vary. The key catalysts ahead include upcoming quarterly earnings and guidance, which often prompt target revisions, plus any holiday-season commentary on store traffic. Broader consumer discretionary trends, promotional activity in retail, and further analyst adjustments will also matter, given how frequent and occasionally mixed those changes have been for this name.

Using AI Daily Buy/Sell Signals in Practice

I have found Tickeron’s AI Daily Buy/Sell Signals helpful for tracking day-to-day momentum in names like BBWI. The tool applies artificial intelligence across thousands of stocks and ETFs to generate Buy, Sell, or Hold signals based on technical behavior and market conditions. For investors combining fundamental views with shorter-term signals, it offers a practical way to stay updated without constant manual screening.

Final Assessment

Whether Bath & Body Works can reach $23 ultimately depends on its ability to stabilize revenue and persuade a cautious analyst community to raise estimates. The target represents the average of recent price targets clustered between $20 and $25, requiring about a 22% advance from current levels. Support comes from inexpensive valuation, a solid dividend, and a recent earnings beat, while obstacles include ongoing sales pressure, mostly "Hold" ratings, and a wide range of analyst views that includes targets below the current price. The outcome remains plausible if fundamentals improve, but it is not assured and will hinge on holiday results, guidance, and consumer spending trends.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BBWI

BBWI's Stochastic Oscillator is sitting in oversold zone for 9 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for BBWI crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.

Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBWI advanced for three days, in 194 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

BBWI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 85 of 145 cases where BBWI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The 10-day RSI Indicator for BBWI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 19 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BBWI as a result. In 64 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

The Moving Average Convergence Divergence Histogram (MACD) for BBWI turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 36 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

BBWI moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBWI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.079) is normal, around the industry mean (2.178). P/E Ratio (5.606) is within average values for comparable stocks, (18.032). Projected Growth (PEG Ratio) (0.658) is also within normal values, averaging (1.159). Dividend Yield (0.037) settles around the average of (0.102) among similar stocks. P/S Ratio (0.472) is also within normal values, averaging (1.080).

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. BBWI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBWI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ulta Beauty (NASDAQ:ULTA), Best Buy Company (NYSE:BBY), Tractor Supply Co (NASDAQ:TSCO), Five Below (NASDAQ:FIVE), GameStop Corp (NYSE:GME), Bath & Body Works (NYSE:BBWI), RH (NYSE:RH), 1-800-FLOWERS.COM (NASDAQ:FLWS).

Industry description

The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.

Market Cap

The average market capitalization across the Specialty Stores Industry is 4.81B. The market cap for tickers in the group ranges from 3.1K to 50.98B. ANCTF holds the highest valuation in this group at 50.98B. The lowest valued company is SIMPQ at 3.1K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Stores Industry was -7%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 5%. QVCG experienced the highest price growth at 14%, while FLWS experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Specialty Stores Industry was 42%. For the same stocks of the Industry, the average monthly volume growth was 26% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 57
Price Growth Rating: 53
SMR Rating: 61
Profit Risk Rating: 88
Seasonality Score: 2 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of retail business

Industry SpecialtyStores

Industry
Apparel Or Footwear Retail
Address
Three Limited Parkway
Phone
+1 614 415-7000
Employees
60735
Web
https://www.bbwinc.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.
Bath & Body Works (BBWI): +22% Upside to the $23 Analyst Target